Trial Profile
Therapy monitoring of omalizumab in children and adolescents with severe allergic asthma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Pharmacodynamics
- 06 Jun 2014 New trial record